Observational studyMedicine2025
The impact of prepregnancy overweight and obesity on newborn glucose-lipid metabolism: An observational study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study seeks to explore the association between maternal prepregnancy excessive weight and metabolic changes in glucose and lipids during early gestation, with a particular focus on its implications for neonatal metabolic health. The results aim to support the development of evidence-based strategies that enhance maternal metabolic health before conception, ultimately promoting better neonatal outcomes. This study included 1467 women of reproductive age who were registered in a community in Huangpu District, Shanghai, between 2017 and 2021. Based on their prepregnancy body mass index, participants were classified into an overweight/obese group and a normal-weight group. The study compared neonatal metabolic indicators from offspring delivered by the 2 maternal groups, including triglycerides (TG), total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose, leptin, fasting insulin, and the insulin resistance index, to evaluate the potential impact of maternal prepregnancy weight status on neonatal metabolic health. Newborns delivered by mothers in the overweight/obese group exhibited significantly higher levels of leptin, triglycerides (TG), total cholesterol, low-density lipoprotein cholesterol (LDL-C), fasting insulin, fasting blood glucose, and insulin resistance index. In comparison, levels of high-density lipoprotein cholesterol (HDL-C) were significantly lower compared to those born to mothers in the normal-weight group (P < .05). Preconception overweight and obesity are closely associated with neonatal glucose and lipid metabolism. Implementing effective weight management strategies before pregnancy is essential for optimizing neonatal metabolic health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.